Effect of WEB 2170 BS, platelet activating factor receptor inhibitor, in the guinea pig model of middle ear inflammation

Annals of Otology, Rhinology and Laryngology

Volumn 109, Issue 6, 2000, Pages 549-553

  Karasen, R Murat ^a,b   Sutbeyaz, Yavuz ^a   Ozdemir, Hasan ^b   Aktan, Bulent ^a   Gundogdu, Cemal ^a  

^a ATATURK UNIVERSITY   (Turkey)

^b ATATÜRK UNIVERSITY   (Turkey)

Author keywords

Animal model of otitis media; Platelet activating factor; Platelet activating factor antagonist; WEB 2170 BS

Indexed keywords

BEPAFANT; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GUINEA PIG; HISTOPATHOLOGY; INFLAMMATORY CELL; MEDIATOR RELEASE; NONHUMAN; OTITIS MEDIA; PATHOGENESIS; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

EID: 0033918860     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940010900604     Document Type: Article

References (19)

1. Rhee C-K, Jung TTK, Miller S, Weeks D. Experimental otitis media with effusion induced by platelet activating factor. Ann Otol Rhinol Laryngol 1993;102:600-5.
2. Sutbeyaz Y, Yakan B, Ozdemir H, Karasen M, Doner F, Kufrevioglu I. Effect of SC-41930, a potent selective leukotriene B4 receptor antagonist, in the guinea pig model of middle ear inflammation. Ann Otol Rhinol Laryngol 1996;105:476-80.
3. Jung TTK, Rhee CK, Park YS, Choi DJ, Miller S, Weeks D. Effect of the inhibitors of leukotriene and platelet activating factor on killed H influenzae-induced experimental otitis media. In: Mogi G, Honjo I, Ishii T, Takasaka T, eds. Recent advances in otitis media. Amsterdam, the Netherlands: Kugler, 1994:661-5.
4. Jung TTK, Shea D.,Giebink GS, Juhn SK. Comparative histopathology of animal models of otitis media in chinchillas: a temporal bone study. In: Lim DJ, Bluestone CD, Klein JO, Nelson JD, eds. Recent advances in otitis media with effusion. Philadelphia, Pa: BC Decker, 1984:91-6.
5. Jung TTK, Rhee CK. Otolaryngologic approach to the diagnosis and management of otitis media. Otolaryngol Clin North Am 1991;24:931-45.
6. Cauwenberge P, Bernstein J. Inflammatory mediators in middle ear disease. In: Bernstein J, Ogra P, eds. Immunology of the ear. New York. NY: Raven Press, 1987:338-9.
7. Barnes P, Chung K, Page C. Platelet activating factor as a mediator of allergic disease. J Allergy Clin Immunol 1988;81: 919-34.
8. Lin J, Kim Y, Lees C, Juhn SK. Effects of platelet activating factor (PAF) receptor blockage on mucous glycoprotein secretion in cultured chinchilla middle ear epithelium. Acta Otolaryngol (Stockh) 1996;116:69-73.
9. Casals-Stenzel J, Muacevic G, Weber KH. Pharmacological actions of Web 2086, a new specific antagonist of platelet activating factor. J Pharmacol Exp Ther 1987;241:974-81.
10. Casals-Stenzel J, Weber KH. Triazolodiazepines: dissociation of their Paf (platelet activating factor) antagonistic and CNS activity. Br J Pharmacol 1987;90:139-46.
11. Heuer HO. Pharmacology of hetrazepines as Paf-antagonists. In: Braquet P. ed. Handbook of Paf and Paf antagonists. Boca Raton, Fla: CRC Press, 1991:171-202.
12. Baron EJ, Finegold SM. Diagnostic microbiology. Philadelphia. Pa: CV Mosby, 1990:171-94.
13. Lin J, Kim Y, Lees C, Juhn SK. Effects of platelet activating factor on secretion of mucous glycoprotein from cultured middle ear epithelial cells. Eur Arch Otorhinolaryngol 1995;252:92-6.
14. Calumbo M, Casolaro V, Warner J, MacGlashan D, Kagey-Sobotka A, Lichtenstein L. The mechanism of mediator release from human basophils induced by platelet activating factor. J Immunol 1990;145:3855-61.
15. Martins MA, Silva PM, Faria Neto HC, et al. Pharmacological modulation of PAF-induced rat pleurisy and its role in inflammation by zymosan. Br J Pharmacol 1989;96:363-71.
16. Giembycz M, Kroegel C, Barnes P. Platelet activating factor stimulates cyclo-oxygenase activity in guinea pig eosinophils. J Immunol 1990;144:3489-97.
17. Boughton-Smith NK, Wallace JL, Whittle JR. Relationships between arachidonic acid metabolism, myeloperoxidase activity and leukocyte infiltration in rat model of inflammatory bowel disease. Agents Actions 1988;25:115-23.
18. Nakashima S, Suganuma A. Sato M. Tohmatsu T, Nozawa Y. Mechanism of arachidonic acid liberation in platelet-activating factor-stimulated human polymorphonuclear neutrophils. J Immunol 1989;143:1295-302.
19. Voelkel N, Worthen S, Reeves J, Henson P, Murphy R. Nonimmunological production of leukotrienes induced by platelet-activating factor. Science 1982;218:286-8.